Loading...
Pulse Biosciences, Inc.
PLSE•NASDAQ
Healthcare
Medical - Instruments & Supplies
$14.93
$0.06(0.40%)
Pulse Biosciences, Inc. (PLSE) Financial Performance & Income Statement Overview
Review Pulse Biosciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-29.11%
↓ 29.11%
Net Income Growth
-26.95%
↓ 26.95%
Operating Cash Flow Growth
-9.99%
↓ 9.99%
Operating Margin
-7654.57%
↓ 7654.57%
Gross Margin
-64.06%
↓ 64.06%
Net Profit Margin
-7240.75%
↓ 7240.75%
ROE
-71.00%
↓ 71.00%
ROIC
-50.70%
↓ 50.70%
Pulse Biosciences, Inc. (PLSE) Income Statement & Financial Overview
Review Pulse Biosciences, Inc.'s (PLSE) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $832000.00 | $0.00 | $0.00 | $0.00 |
Cost of Revenue | $832000.00 | $267000.00 | $266000.00 | $299000.00 |
Gross Profit | $0.00 | -$267000.00 | -$266000.00 | -$299000.00 |
Gross Profit Ratio | $0.00 | |||
R&D Expenses | $10.66M | $7.70M | $7.23M | $6.74M |
SG&A Expenses | $10.16M | $5.95M | $4.23M | $3.58M |
Operating Expenses | $20.26M | $13.65M | $11.46M | $10.32M |
Total Costs & Expenses | $21.66M | $13.65M | $11.73M | $10.62M |
Interest Income | $0.00 | $975000.00 | $343000.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $478000.00 |
Depreciation & Amortization | $287000.00 | $294000.00 | $266000.00 | $299000.00 |
EBITDA | -$19.97M | -$13.36M | -$11.43M | -$10.32M |
EBITDA Ratio | -$24.007 | |||
Operating Income | -$20.26M | -$13.65M | -$11.73M | -$10.62M |
Operating Income Ratio | -$24.35 | |||
Other Income/Expenses (Net) | $876000.00 | $975000.00 | $343000.00 | $478000.00 |
Income Before Tax | -$19.39M | -$12.68M | -$11.38M | -$10.14M |
Income Before Tax Ratio | -$23.30 | |||
Income Tax Expense | $0.00 | $0.00 | $0.00 | $255724.00 |
Net Income | -$19.39M | -$12.68M | -$11.38M | -$10.14M |
Net Income Ratio | -$23.30 | |||
EPS | -$0.32 | -$0.21 | -$0.20 | -$0.18 |
Diluted EPS | -$0.32 | -$0.21 | -$0.20 | -$0.18 |
Weighted Avg Shares Outstanding | $58.40M | $61.07M | $57.18M | $55.17M |
Weighted Avg Shares Outstanding (Diluted) | $58.40M | $61.07M | $57.18M | $55.17M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan